An overview of hereditary spherocytosis and the curative effects of splenectomy
Frontiers in Physiology · 11.02.2025 · 16
DOI: 10.3389/fphys.2025.1497588 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Physiology, online erschienen am 11.02.2025. Verfasst von Kyril Turpaev und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Theoretical Problems of Physicochemical Pharmacology, Russian Academy of Sciences, Moscow, Russia. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Hereditary spherocytosis is a common hemolytic anemia with different severity. The causes of hereditary spherocytosis are mutations in genes that encode red blood cell (RBC) membrane and cytoskeletal proteins, including ankyrin-1, Band 3 (or AE1), α spectrin, β spectrin, and protein 4.2. Molecular defects in these proteins decrease membrane integrity, leading to vesiculation, decreased membrane surface area, and reduced deformability of the cells. Eventually, this leads to the trapping the abnormal RBCs (spherocytes) in the spleen. In most severe cases, splenectomy may be necessary to prevent general RBC collapse during the passage of RBCs through the narrow slits of venous sinuses in the spleen. The clinical benefit of splenectomy results from elimination the primary site of RBC damage and destruction. Splenectomy is a curative approach but can cause complications and should be undertaken after examination by various laboratory approaches. Splenectomy does not correct most genetically determined membrane abnormalities in erythrocytes in patients with hereditary spherocytosis. The transformation of biconcave erythrocytes into spherocytes continues, although to a lesser degree than before surgery. Nevertheless, splenectomy increases the lifespan of red cells, significantly reducing the severity of anemia and improving many physiological signs of HS.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Theoretical Problems of Physicochemical Pharmacology, Russian Academy of Sciences, Moscow, Russia.
- Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia.
- Moscow Institute of Physics and Technology, National Research University, Dolgoprudny, Russia.
- Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Zitieren
APA
Turpaev, K., Bovt, E., Shakhidzhanov, S., Sinauridze, E., Smetanina, N., Koleva, L., Kushnir, N., Suvorova, A., & Ataullakhanov, F. (2025). An overview of hereditary spherocytosis and the curative effects of splenectomy. Frontiers in Physiology, 16. https://doi.org/10.3389/fphys.2025.1497588
Vancouver
Turpaev K, Bovt E, Shakhidzhanov S, Sinauridze E, Smetanina N, Koleva L, et al. An overview of hereditary spherocytosis and the curative effects of splenectomy. Frontiers in Physiology. 2025;16. doi:10.3389/fphys.2025.1497588
BibTeX
@article{Turpaev2025,
author = {Turpaev, Kyril and Bovt, Elizaveta and Shakhidzhanov, Soslan and Sinauridze, Elena and Smetanina, Nataliya and Koleva, Larisa and Kushnir, Nikita and Suvorova, Anna and Ataullakhanov, Fazoil},
title = {An overview of hereditary spherocytosis and the curative effects of splenectomy},
journal = {Frontiers in Physiology},
year = {2025},
volume = {16},
doi = {10.3389/fphys.2025.1497588}
}
EUVIMED